EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

CD163+ Tumor-Associated Macrophage Recruitment Predicts Papillary Thyroid Cancer Recurrence

Hiroshi Katoh, Riku Okamoto, Mitsuo Yokota, Kanako Naito, Mariko Kikuchi, Takaaki Tokito, Takafumi Sangai, Keishi Yamashita

Journal of Surgical Research · 2024

DOI: 10.1016/j.jss.2024.09.035 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Surgical Research, 2024. Verfasst von Hiroshi Katoh und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Breast and Thyroid Surgery, Kitasato University Hospital, Sagamihara, Kanagawa, Japan. Electronic address: hiroshik@med.kitasato-u.ac.j…. Hauptthemen laut MEDLINE: Antigens, Differentiation, Myelomonocytic, Antigens, CD, Receptors, Cell Surface, Thyroid Cancer, Papillary. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Yasuda Memorial Medical Foundation, Japan Society for the Promotion of Science, Kanae Foundation for the Promotion of Medical Science.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION: Skewed immune response plays a pivotal role in tumor progression. Systemic inflammatory responses represented by combined peripheral leukocyte fractions are prognostic predictors of multiple cancers, including thyroid cancer. We previously reported the prognostic significance of lymphocyte-to-monocyte ratio (LMR) in curatively resected papillary thyroid cancer (PTC). Therefore, this study aimed to analyze immune cell profiles in the tumor microenvironment and their association with LMR in curatively resected PTC. MATERIALS AND METHODS: The immune cell profiles of primary tumors in 162 patients with curatively resected PTC were analyzed clinicopathologically. Immunohistochemistry of tumor-associated macrophages (TAMs), myeloid-derived suppressor cells, and lymphocytes was performed using CD163, CD33, and CD3 antibodies, respectively. Prognostic analysis and correlation assays were performed using the immunocyte profiles. The gene expression of tumor-derived chemokines was assessed using a The Cancer Genome Atlas database. RESULTS: Patients with a higher density of CD163+ TAMs exhibited a significantly worse prognosis than their counterparts (10-y recurrence-free survival: 80.9% versus 91.2%, P = 0.011). Multivariate prognostic analyses revealed that high CD163+ cell density (P = 0.011), low preoperative LMR (P = 0.003), pN1b (P = 0.005), and high thyroglobulin level (P = 0.038) were independent predictors of recurrence. High CD163+ cell density had a prognostic impact on stage II and III PTC. Interestingly, high CD163+ cell density correlated with low LMR and high monocyte fraction in peripheral blood. Indeed, the expression of TAM-inducible, tumor-derived chemokines is increased in the The Cancer Genome Atlas database. CONCLUSIONS: A high density of infiltrated CD163+ TAMs predicts recurrence in correlation with low LMR and circulating monocyte accumulation. Thus, TAMs should be considered when assessing advanced PTC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antigens, Differentiation, MyelomonocyticAntigens, CDReceptors, Cell SurfaceThyroid Cancer, PapillaryThyroid NeoplasmsNeoplasm Recurrence, LocalTumor MicroenvironmentTumor-Associated MacrophagesHumansMaleFemaleMiddle AgedAdultPrognosisAgedThyroidectomyMonocytesCD163 Antigen

Stichwörter der Autor:innen

CD163LMRPapillary thyroid cancerTAMTumor-associated macrophage

Substanzen

CD163 AntigenAntigens, Differentiation, MyelomonocyticAntigens, CDReceptors, Cell Surface

Autor:innen und Institutionen

  • Department of Breast and Thyroid Surgery, Kitasato University Hospital, Sagamihara, Kanagawa, Japan. Electronic address: hiroshik@med.kitasato-u.ac.jp.
  • Department of Breast and Thyroid Surgery, Kitasato University Hospital, Sagamihara, Kanagawa, Japan.
  • Division of Advanced Surgical Oncology, Research and Development Center for New Medical Frontiers, Kitasato University School of Medicine, Sagamihara, Kanagawa, Japan.

Förderung

  • Yasuda Memorial Medical Foundation
  • Japan Society for the Promotion of Science
  • Kanae Foundation for the Promotion of Medical Science

Zitieren

APA

Katoh, H., Okamoto, R., Yokota, M., Naito, K., Kikuchi, M., Tokito, T., Sangai, T., & Yamashita, K. (2024). CD163+ Tumor-Associated Macrophage Recruitment Predicts Papillary Thyroid Cancer Recurrence. Journal of Surgical Research. https://doi.org/10.1016/j.jss.2024.09.035

Vancouver

Katoh H, Okamoto R, Yokota M, Naito K, Kikuchi M, Tokito T, et al. CD163+ Tumor-Associated Macrophage Recruitment Predicts Papillary Thyroid Cancer Recurrence. Journal of Surgical Research. 2024. doi:10.1016/j.jss.2024.09.035

BibTeX
@article{Katoh2024,
  author = {Katoh, Hiroshi and Okamoto, Riku and Yokota, Mitsuo and Naito, Kanako and Kikuchi, Mariko and Tokito, Takaaki and Sangai, Takafumi and Yamashita, Keishi},
  title = {CD163+ Tumor-Associated Macrophage Recruitment Predicts Papillary Thyroid Cancer Recurrence},
  journal = {Journal of Surgical Research},
  year = {2024},
  doi = {10.1016/j.jss.2024.09.035}
}
Kostenlos starten →